FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
Innovative physician-scientist specializing in head and neck, pancreatic cancers also known as influential mentor
9071 Background: Despite its direct correlation with quality of life, sexual dysfunction is under-discussed and underreported in patients with lung cancer (LC). Sexual dysfunction is…
Walmart, the largest retailer in the United States, will close all 51 of its health care clinics in six states and end virtual health care…
FDA is alerting health care professionals of the rare risk of intrahepatic cholestasis of pregnancy (ICP) associated with the use of thiopurines.
One zebra was still on the loose, after it and three others escaped a trailer in North Bend, Wash. Dozens of people scrambled to help…
CA: A Cancer Journal for Clinicians is ACS’ flagship clinical oncology journal publishing information about the prevention, early detection, and treatment of cancer.
Providers at the @OSUCCC_James Cancer and Aging Resiliency (CARE) Clinic are addressing overall health and quality of life to help improve cancer outcomes in older…
Cigna tracks every minute that its staff doctors spend deciding whether to pay for health care. Dr. Debby Day said her bosses cared more about…
Breast cancer cases are increasing among younger women, which means it now makes sense to start regular screening younger, a federal task force says.